| Metric | Value (₹ Cr) | vs Q2 FY25 |
|---|---|---|
| Revenue | 464.11 | 9.7% |
| Total Income | 482.94 | 12.0% |
| Expenditure | 431.76 | 5.8% |
| PBT | 51.18 | 43.1% |
| Net Profit | 37.04 | 48.6% |
| OPM | 3.89% | 3.98pp |
| NPM | 7.67% | 5.46pp |
| EPS | 2.28 | 48.5% |
FDC Limited Reports 9.1% Revenue Growth in 9MFY25; API Business Grows 25.1% YoY
12 Feb 2025 · 12 Feb 2025, 11:49 pm
Summary
FDC Limited, a manufacturer and exporter of foods, drugs, and chemicals, reported financial results for the quarter and nine months ended December 31, 2024. The company delivered a 9.1% revenue growth in 9MFY25, driven by robust performance across all business segments, except for US Formulations, which witnessed a 20.7% YoY decline. The API business demonstrated strong momentum, recording a 25.6% YoY growth in Q3FY25 and 25.1% YoY growth in 9MFY25. However, EBITDA for Q3FY25 and 9MFY25 was impacted by lower sales in the export formulation business, price reduction in the Electral range of products, changes in the product mix, and higher employee costs.
Key Highlights
- 1
FDC Limited reported a 9.1% revenue growth in 9MFY25
- 2
The API business showed a 25.6% YoY growth in Q3FY25
- 3
Export formulations business witnessed a 20.7% YoY decline in 9MFY25
- 4
EBITDA for Q3FY25 and 9MFY25 was impacted by various factors
- 5
FDC Limited is a manufacturer and exporter of foods, drugs, and chemicals
Management Comments
Company spokesperson
The company delivered revenue growth of 9.1% in 9MFY25, driven by robust performance across all business segments, except for US Formulations. The export formulations business witnessed a 20.7% YoY decline in 9MFY25, primarily due to lower sales in the US market. On the other hand, the API business demonstrated strong momentum, recording a 25.6% YoY growth in Q3FY25 and 25.1% YoY growth in 9MFY25. EBITDA for Q3FY25 and 9MFY25 was impacted by lower sales in export formulation business, price reduction in the Electral range of products, driven by NLEM price revisions changes in the product mix, and higher employee costs.
Informational and educational content only. Not investment advice.